Why I still own Pro Medicus Limited (ASX:PME) & Xero Limited (ASX:XRO) shares
Pro Medicus Ltd (ASX:PME) shares and Xero Limited (ASX:XRO) shares my two biggest ASX shareholdings. If you want to know why I own Pro Medicus or Xero shares, read this.
Pro Medicus Ltd (ASX:PME) shares and Xero Limited (ASX:XRO) shares my two biggest ASX shareholdings. If you want to know why I own Pro Medicus or Xero shares, read this.
US stock markets will offer a negative lead for the S&P/ASX 200 (INDEXASX: XJO) today as all three benchmarks finished lower overnight.
The S&P/ASX 200 (ASX:XJO) delivered a 0.5% weekly loss, again outperforming US markets which fell by more than 2%. Here are my key takeaways.
It was another rough day for US stock markets to start the week as Twitter (NYSE:TWTR) and Shopify (NYSE:SHOP) shares were in the news.
In this Australian Investors Podcast, Owen Rask is joined by Dr Anirban Mahanti, PhD to discuss the recent sell-off of 6 popular technology stocks. These 6 companies/stocks are trading at, or near, their 52-week lows. However, many of these companies are still reporting growth in revenue and cash flow.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024